Synonyms: AC-430
Compound class:
Synthetic organic
Comment: AC430 is an investigational, potent and selective small molecule inhibitor of janus kinase 2 (JAK2) being developed by Ambit (now owned by Daiichi Sankyo) for the treatment of cancer and autoimmune diseases. AC430 is the (R) optical isomer claimed in patent US8703943 [1], although the (S) isomer and racemate are also discussed in the patent descriptions.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
(R)-(4-fluorophenyl)-[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]methanol |
Synonyms |
AC-430 |
Database Links | |
GtoPdb PubChem SID | 315661260 |
PubChem CID | 56833309 |
Search Google for chemical match using the InChIKey | DCRWIATZWHLIPN-QGZVFWFLSA-N |
Search Google for chemicals with the same backbone | DCRWIATZWHLIPN |
UniChem Compound Search for chemical match using the InChIKey | DCRWIATZWHLIPN-QGZVFWFLSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | DCRWIATZWHLIPN-QGZVFWFLSA-N |